Observational studyArchives of endocrinology and metabolism2025
Clinical management, economic and quality-of-life impacts among consulting people with obesity in Brazil: results from a real-world survey.
Observational study in Archives of endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Obesity Severity and Burden of Illness: Perceptions From Physicians and People With Obesity in the UK.Obesity science & practice · 2026Article
- Impact of Obesity on Individuals in Saudi Arabia: A Real-World Patient and Physician Survey.Advances in therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveObesity prevalence is increasing in Brazil. Real-world observational data were used to understand clinical weight management practice, and the economic and health-related quality-of-life (HRQoL) impact of obesity. MATERIALS AND
methodsData were derived from the Adelphi Real World Obesity Disease Specific Programme (DSP)™, a cross-sectional survey of people with obesity (PwO) and treating physicians, conducted in Brazil May-October 2022. Physicians reported demographic/clinical characteristics and current/previous weight management. PwO reported emotional/financial impact of obesity, and completed patient-reported outcomes on HRQoL, and activity/work impairment.
resultsIn total, 99 physicians reported on 895 PwO. Mean ± SD PwO age was 43.1 ± 13.7, majority were female (60.9%) and white (71.7%). Mean ± SD BMI at survey was 33.8 ± 9.4 with 40.5%, 23.2% and 11.1% of PwO having class 1, 2 or 3 obesity. Weight management was most commonly at PwO request (43.4%), and consisted of prescription weight loss drug (53.6%), and dietician or physician-supervised diets (79.9% and 55.1%). Most PwO reported financial impact due to obesity treatment and reported being bothered/embarrassed by their weight. SF-36v2 physical summary scores ranged from 52.4 ± 9.3 to 45.6 ± 8.6 and mental summary scores from 45.5 ± 9.3 to 42.2 ± 12.3 (BMI < 30 to class 3 obesity). Overall work and activity impairment ranged from 20.0 ± 22.7 to 42.4 ± 28.4 (BMI < 30 and class 2 obesity) and from 24.7 ± 25.2 to 43.2 ± 32.5 (BMI < 30 to class 3 obesity), and 3.2% did not work due to obesity.
conclusionPwO have a substantial impact on work, and financial, emotional and quality-of-life burden. Our data highlight the need for more efficacious obesity management, to help reduce work and activity impairment, improve quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.